These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis. Mori T, Aisa Y, Yamazaki R, Mihara A, Ikeda Y, Okamoto S. Bone Marrow Transplant; 2006 Nov; 38(9):637-8. PubMed ID: 16953203 [No Abstract] [Full Text] [Related]
3. Prevention of high dose L-PAM-induced mucositis by cryotherapy. Dumontet C, Sonnet A, Bastion Y, Salles G, Espinouse D, Coiffier B. Bone Marrow Transplant; 1994 Sep; 14(3):492-4. PubMed ID: 7994283 [No Abstract] [Full Text] [Related]
5. Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Gori E, Arpinati M, Bonifazi F, Errico A, Mega A, Alberani F, Sabbi V, Costazza G, Leanza S, Borrelli C, Berni M, Feraut C, Polato E, Altieri MC, Pirola E, Loddo MC, Banfi M, Barzetti L, Calza S, Brignoli C, Bandini G, De Vivo A, Bosi A, Baccarani M. Bone Marrow Transplant; 2007 Mar; 39(6):347-52. PubMed ID: 17277790 [Abstract] [Full Text] [Related]
8. Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Aisa Y, Mori T, Kudo M, Yashima T, Kondo S, Yokoyama A, Ikeda Y, Okamoto S. Support Care Cancer; 2005 Apr; 13(4):266-9. PubMed ID: 15668755 [Abstract] [Full Text] [Related]
9. Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver. Vahrmeijer AL, van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME, Marinelli A, Kuppen PJ, van Bockel JH, Mulder GJ, van de Velde CJ. Br J Cancer; 2000 May; 82(9):1539-46. PubMed ID: 10789721 [Abstract] [Full Text] [Related]
10. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. McCann S, Schwenkglenks M, Bacon P, Einsele H, D'Addio A, Maertens J, Niederwieser D, Rabitsch W, Roosaar A, Ruutu T, Schouten H, Stone R, Vorkurka S, Quinn B, Blijlevens N, EBMT Mucositis Advisory Group. Bone Marrow Transplant; 2009 Jan; 43(2):141-7. PubMed ID: 18776926 [Abstract] [Full Text] [Related]
12. Chemotherapy: the effect of oral cryotherapy on the development of mucositis. Karagözoğlu S, Filiz Ulusoy M. J Clin Nurs; 2005 Jul; 14(6):754-65. PubMed ID: 15946284 [Abstract] [Full Text] [Related]
19. [Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation]. Imataki O, Aoyama T, Tamai Y, Kawakami K. Gan To Kagaku Ryoho; 2007 Oct; 34(10):1633-6. PubMed ID: 17940379 [Abstract] [Full Text] [Related]